We are live on
!
Find out more
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Portfolio holdings
AUM
$533M
1-Year Est. Return
65.58%
This Fund
S&P 500
This Quarter
Est. Return
-8.24%
1 Year Est. Return
+65.58%
3 Year Est. Return
+141.73%
5 Year Est. Return
+93.46%
10 Year Est. Return
+1,196.58%
AUM
$1.77B
AUM Growth
+$177M
(+11%)
Cap. Flow
+$352M
Cap. Flow
% of AUM
19.88%
Top 10 Holdings %
Top 10 Hldgs %
97.54%
Holding
48
New
6
Increased
3
Reduced
2
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$262M |
| 2 |
Microsoft
MSFT
|
+$200M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$114M |
| 4 |
LNW
Light & Wonder
LNW
|
+$26.6M |
| 5 |
GRNA
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
|
+$15.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EQT Corp
EQT
|
+$154M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$110M |
| 3 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
+$3.13M |
| 4 |
Nautilus Biotechnolgy
NAUT
|
+$1.6M |
| 5 |
Douglas Emmett
DEI
|
+$1.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 62.83% |
| 2 | Communication Services | 12.01% |
| 3 | Technology | 11.8% |
| 4 | Consumer Discretionary | 7.42% |
| 5 | Healthcare | 3.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares MSCI EAFE ETF
EFA
$78B
| $416M | 23.52% |
5,653,424
+3,505,000
| +163% | +$262M |
|
2
iShares MSCI Emerging Markets ETF
EEM
$31.6B
| $375M | 21.21% |
8,313,046
| – | – |
|
3
iShares Core MSCI Emerging Markets ETF
IEMG
$163B
| $320M | 18.06% |
5,752,009
| – | – |
|
|
4
Alphabet (Google) Class A
GOOGL
$4.21T
| $212M | 12% |
1,526,620
+841,620
| +123% | +$114M |
|
|
5
Microsoft
MSFT
$3.83T
| $205M | 11.6% |
+665,738
| New | +$200M |
|
|
LNW
6
DELISTED
Light & Wonder
LNW
| $73.6M | 4.16% |
1,253,039
+440,147
| +54% | +$26.6M |
|
7
QuantumScape Corp
QS
$3.02B
| $57.5M | 3.25% |
2,874,742
| – | – |
|
8
Krispy Kreme
DNUT
$501M
| $32.5M | 1.84% |
2,187,760
| – | – |
|
|
AKYA
9
DELISTED
Akoya BioSciences
AKYA
| $17.3M | 0.98% |
1,572,863
-52,695
| -3% | -$611K |
|
|
GRNA
10
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
| $16.4M | 0.93% |
+1,706,078
| New | +$15.3M |
|
11
Lyell Immunopharma
LYEL
$241M
| $8.32M | 0.47% |
82,394
| – | – |
|
12
Kodiak Sciences
KOD
$2.03B
| $5.34M | 0.3% |
691,767
| – | – |
|
|
LENZ
13
LENZ Therapeutics
LENZ
$123M
| $3.58M | 0.2% |
100,439
| – | – |
|
14
BridgeBio Pharma
BBIO
$12.8B
| $3.36M | 0.19% |
331,283
| – | – |
|
15
Surrozen
SRZN
$347M
| $2.43M | 0.14% |
53,758
| – | – |
|
16
Doximity
DOCS
$4.7B
| $2.16M | 0.12% |
41,484
| – | – |
|
|
CFLT
17
DELISTED
Confluent
CFLT
| $2.13M | 0.12% |
+51,876
| New | +$2.7M |
|
18
Black Stone Minerals
BSM
$3.07B
| $1.99M | 0.11% |
147,852
| – | – |
|
19
Bolt Biotherapeutics
BOLT
$6.9M
| $1.97M | 0.11% |
35,977
| – | – |
|
20
Kimbell Royalty Partners
KRP
$1.47B
| $1.82M | 0.1% |
111,638
| – | – |
|
21
Annexon
ANNX
$690M
| $1.32M | 0.07% |
482,550
| – | – |
|
22
Planet Labs
PL
$6.34B
| $1.3M | 0.07% |
256,445
| – | – |
|
|
DICE
23
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $1.12M | 0.06% |
58,492
-175,422
| -75% | -$3.13M |
|
24
DigitalOcean
DOCN
$16.4B
| $1.05M | 0.06% |
18,147
| – | – |
|
25
KALA BIO
KALA
$9.2M
| $950K | 0.05% |
+276
| New | +$723K |
|
Similar funds
TCMX
RCI
SIA
CCM
3IP
S
BCM
SCP
Board of Trustees of The Leland Stanford Junior University's Q1 2022 Portfolio in Review
As of Q1 2022, Board of Trustees of The Leland Stanford Junior University held 48 positions worth $1.77B, up 11% from $1.59B the previous quarter. Its ten largest holdings account for 98% of the portfolio.
Board of Trustees of The Leland Stanford Junior University deployed $352M of net new capital in Q1 2022, opening 6 new positions and adding to 3 existing holdings. Its largest new stake was Microsoft: 665,738 shares worth $205M.
By sector, the portfolio is most concentrated in Miscellaneous at 63% of assets, down from 65% a quarter earlier, followed by Communication Services and Technology.
On the sell side, the largest reduction was DICE Therapeutics, Inc. Common Stock, an estimated $3.13M trimmed.
- Board of Trustees of The Leland Stanford Junior University's largest Q1 2022 buy was Microsoft: 665,738 shares worth $205M.
- Board of Trustees of The Leland Stanford Junior University added most to iShares MSCI EAFE ETF in Q1 2022, an estimated $262M increase.
- Board of Trustees of The Leland Stanford Junior University's biggest Q1 2022 reduction was DICE Therapeutics, Inc. Common Stock, cutting an estimated $3.13M.
- Board of Trustees of The Leland Stanford Junior University fully exited EQT Corp in Q1 2022, selling an estimated $154M.
- Board of Trustees of The Leland Stanford Junior University's ten largest holdings make up 98% of its $1.77B portfolio in Q1 2022.
- Board of Trustees of The Leland Stanford Junior University opened 6 new positions and closed 8 in Q1 2022.
- Board of Trustees of The Leland Stanford Junior University's portfolio value rose 11% quarter-over-quarter to $1.77B.
Based on Board of Trustees of The Leland Stanford Junior University's 13F filing for Q1 2022, filed 13 May 2022.